NeueHealth, Inc. (NYSE:NEUE – Get Free Report) CFO Jay Matushak sold 1,860 shares of the business’s stock in a transaction that occurred on Friday, March 7th. The shares were sold at an average price of $7.19, for a total value of $13,373.40. Following the completion of the sale, the chief financial officer now directly owns 22,227 shares in the company, valued at approximately $159,812.13. The trade was a 7.72 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.
Jay Matushak also recently made the following trade(s):
- On Monday, January 6th, Jay Matushak sold 4,970 shares of NeueHealth stock. The shares were sold at an average price of $7.33, for a total value of $36,430.10.
NeueHealth Stock Down 2.3 %
Shares of NYSE NEUE opened at $6.77 on Thursday. NeueHealth, Inc. has a 52-week low of $3.79 and a 52-week high of $7.73. The business’s 50 day moving average is $7.32 and its two-hundred day moving average is $5.99. The firm has a market cap of $56.09 million, a price-to-earnings ratio of -0.13 and a beta of 0.56.
Institutional Trading of NeueHealth
Analyst Upgrades and Downgrades
Separately, Royal Bank of Canada cut their target price on NeueHealth from $8.00 to $7.00 and set a “sector perform” rating on the stock in a research report on Monday, December 9th.
Read Our Latest Report on NeueHealth
About NeueHealth
NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.
Further Reading
- Five stocks we like better than NeueHealth
- What does consumer price index measure?
- Ramaco Resources Pins Hopes on Coal’s Untapped Potential
- How to Invest in Blue Chip Stocks
- NVIDIA’s Soaring Energy Needs Make These 3 Nuclear Stocks a Buy
- Stock Splits, Do They Really Impact Investors?
- Why Energy Transfer Belongs on Your Watchlist
Receive News & Ratings for NeueHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NeueHealth and related companies with MarketBeat.com's FREE daily email newsletter.